While this and other BDNF variants have received much attention in recent years in relation to a variety of diseases and outcome measures such as neuropsychiatric disorders, Alzheimer's [13], multiple sclerosis [14], and Parkinson's [15], clinical studies in stroke are limited. This evidence concerns the gene BDNF and Stroke.